Literature DB >> 34220014

Prevalence of K-ras Codon 12 Mutations in Indian Patients with Head and Neck Cancer.

Ashna Gauthaman1, Anbalagan Moorthy1.   

Abstract

In human tumors, somatic mutation frequently occur in K-ras gene at codon 12, which makes the K-ras protein hyper active leading to uncontrolled signaling for cell division: one of the important hall mark of cancer. In order to correlate mutations in K-ras to cause, response to treatment, disease progression and recurrence of Head and Neck Squamous Cell Carcinoma (HNSCC) the following study was undertaken. By using PCR-RFLP method prevalence of codon 12 in K-ras gene was studied in 56 HNSCC patients. High frequency of K-ras mutation was detected in codon 12 (60.71%). The result of this study helps us in understanding the role of K-ras somatic mutations in HNSCC patients and in designing novel treatment protocols for HNSCC patients. © Association of Clinical Biochemists of India 2020.

Entities:  

Keywords:  Head and neck cancer; K-ras; Mutation; PCR–RFLP

Year:  2020        PMID: 34220014      PMCID: PMC8215005          DOI: 10.1007/s12291-020-00882-w

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  18 in total

1.  Low incidence of H-, K- and N-ras oncogene mutations in cytological specimens of laryngeal tumours.

Authors:  E Rizos; G Sourvinos; D A Arvanitis; G Velegrakis; D A Spandidos
Journal:  Oral Oncol       Date:  1999-11       Impact factor: 5.337

2.  Ras history: The saga continues.

Authors:  Adrienne D Cox; Channing J Der
Journal:  Small GTPases       Date:  2010-07

3.  Relationship between the formation of promutagenic adducts and the activation of the K-ras protooncogene in lung tumors from A/J mice treated with nitrosamines.

Authors:  S A Belinsky; T R Devereux; R R Maronpot; G D Stoner; M W Anderson
Journal:  Cancer Res       Date:  1989-10-01       Impact factor: 12.701

4.  Identification of novel heterozygous Apex 1 gene variant (Glu87Gln) in patients with head and neck cancer of Indian origin.

Authors:  R Abarna; Debnarayan Dutta; P Sneha; C George Priya Doss; M Anbalagan
Journal:  J Cell Biochem       Date:  2018-08-04       Impact factor: 4.429

5.  Analysis of K-ras codon 12 and TP53 mutations in patients with advanced colorectal carcinoma.

Authors:  M Iqbal Parker; G Zhunussova; L Djansugurova; E Khussainova; B Zhunusbekova; G Afonin; D Khaidarova; M Matejcic
Journal:  S Afr Med J       Date:  2015-09-21

Review 6.  Targeting RAS signalling pathways in cancer therapy.

Authors:  Julian Downward
Journal:  Nat Rev Cancer       Date:  2003-01       Impact factor: 60.716

7.  The KRAS-Variant and Cetuximab Response in Head and Neck Squamous Cell Cancer: A Secondary Analysis of a Randomized Clinical Trial.

Authors:  Joanne B Weidhaas; Jonathan Harris; Dörthe Schaue; Allen M Chen; Robert Chin; Rita Axelrod; Adel K El-Naggar; Anurag K Singh; Thomas J Galloway; David Raben; Dian Wang; Chance Matthiesen; Vilija N Avizonis; Rafael R Manon; Omar Yumen; Phuc Felix Nguyen-Tan; Andy Trotti; Heath Skinner; Qiang Zhang; Robert L Ferris; David Sidransky; Christine H Chung
Journal:  JAMA Oncol       Date:  2017-04-01       Impact factor: 31.777

8.  Genomic insights into head and neck cancer.

Authors:  Tim N Beck; Erica A Golemis
Journal:  Cancers Head Neck       Date:  2016-06-03

9.  High incidence of BRAF V600 mutation in Indian patients with head and neck cancer.

Authors:  Ashna Gauthaman; Anbalagan Moorthy
Journal:  Front Biosci (Elite Ed)       Date:  2018-06-01

10.  Prevalence of K-RAS Codons 12 and 13 Mutations in Locally Advanced Head and Neck Squamous Cell Carcinoma and Impact on Clinical Outcomes.

Authors:  Eric Bissada; Olivier Abboud; Zahi Abou Chacra; Louis Guertin; Xiaoduan Weng; Phuc Félix Nguyen-Tan; Jean-Claude Tabet; Eve Thibaudeau; Louise Lambert; Marie-Lise Audet; Bernard Fortin; Denis Soulières
Journal:  Int J Otolaryngol       Date:  2013-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.